Anika Therapeutics Inc.

Anika Therapeutics Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Anika Therapeutics Inc. is not a good growth stock. Anika Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufa...

News

Acadian Asset Management LLC Purchases 21,517 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)
Acadian Asset Management LLC Purchases 21,517 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)

Ticker Report Acadian Asset Management LLC grew its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 5.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned...\n more…

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...\n more…

ANIK Makes Notable Cross Below Critical Moving Average
ANIK Makes Notable Cross Below Critical Moving Average

Market News Video In trading on Wednesday, shares of Anika Therapeutics Inc. (ANIK) crossed below their 200 day moving average of 24.90, changing hands as low as 24.89 per share...\n more…

Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200-Day Moving Average of $25.90
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200-Day Moving Average of $25.90

Ticker Report Anika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $25.90 and traded as high as...\n more…

SG Americas Securities LLC Decreases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK)
SG Americas Securities LLC Decreases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK)

Ticker Report SG Americas Securities LLC decreased its position in Anika Therapeutics, Inc. (NASDAQ:ANIK - Free Report) by 23.1% in the second quarter, according to its most recent 13F filing with the Securities...\n more…

Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update

Ticker Report Anika Therapeutics, Inc. (NASDAQ:ANIK - Get Free Report) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totalling 669,200 shares, a drop...\n more…